作者：
Serena,Di Cosimo [1]
;
Valentina,Appierto [1]
;
Sara,Pizzamiglio [2]
;
Marco,Silvestri [1]
;
José,Baselga [3]
;
Martine,Piccart [4]
;
Jens,Huober [5]
;
Miguel,Izquierdo [6]
;
Lorena,de la Pena [7]
;
Florentine S,Hilbers [8]
;
Evandro,de Azambuja [4]
;
Michael,Untch [9]
;
Lajos,Pusztai [10]
;
Kathleen,Pritchard [11]
;
Paolo,Nuciforo [3]
;
Anne,Vincent-Salomon [12]
;
Fraser,Symmans [13]
;
Giovanni,Apolone [14]
;
Filippo G,de Braud [15]
;
Marilena V,Iorio [16]
;
Paolo,Verderio [2]
;
Maria Grazia,Daidone [1]
作者单位：
Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy.
[1]
Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy.
[2]
Vall D'Hebron Institute of Oncology, 08035 Barcelona, Spain.
[3]
Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), 1000 Brussels, Belgium.
[4]
Department of Obstetrics and Gynecology, University of Ulm, 89081 Ulm, Germany.
[5]
Novartis Pharmaceutical, 4002 Basel, Switzerland.
[6]
SOLTI-Breast Cancer Research Group, 08035 Barcelona, Spain.
[7]
Breast International Group (BIG)-aisbl, 1000 Bruxelles, Belgium.
[8]
Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, 13125 Berlin, Germany.
[9]
Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511, USA.
[10]
Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, M4N 3M5 ON, Canada.
[11]
Groupe d'étude des facteurs pronostiques immunohistochimiques dans le cancer du sein, 75013 Unicancer, France.
[12]
Department of Pathology, The UT M.D. Anderson Cancer Center, Houston, TX 77030, USA.
[13]
Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy.
[14]
Department of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy.
[15]
Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy.
[16]
DOI
10.3390/ijms21041386
PMID
32085669
发布时间
2020-11-30
换一批
换一批
